METHOD FOR PREDICTION OF DEVELOPING MULTIPLE SCLEROSIS TAKING INTO ACCOUNT IMMUNE-METABOLIC VALUES Russian patent published in 2014 - IPC G01N33/49 

FIELD: medicine.

SUBSTANCE: coefficient is calculated with the use of a regression equation: PC=3.12773 - 0.570815*sex - 0.00053521*age+0,0701398*glucose+0.0126693*aspartate aminotransferase - 0.00444583*alanine aminotransferase - 0.0713107*bilirubin+0.104748*thymol test+0.324302*urea+0.00109034*cholesterol - 0.266549*amylase - 0.0371365*total protein+0.166586*lymphocytes - 0.263371*CD3 - 1.90439*CD19 - 0.171236*CD4+0.296383*CD8 - 1.04997*CD16+0.346955*CD11b+0.0512544*"ФЧ"+0.608005*"НСТсп"+0,52123*"НСТак"+0.0105846*IgG - 0.0839649*IgA+0.136765*IgM, wherein females are marked with one, and males are marked with two; age is completed years at the moment of examination. If the coefficient does not exceed 2.36, then the patient is considered to be apparently healthy. If the coefficient falls within the range of 2.37 - 3.10 standard units, the stage of remittance is predicted. If the coefficient is 3.11 or more, the patient suffers the stage of the active clinical course of multiple sclerosis.

EFFECT: using the given method enables predicting the clinical course of multiple sclerosis taking into account the values of the patient's immunological status with the following correction of the therapeutic approach.

1 ex